{"id":2299,"date":"2020-09-24T18:35:05","date_gmt":"2020-09-24T18:35:05","guid":{"rendered":"https:\/\/helvietmed.org\/?page_id=2299"},"modified":"2020-09-24T18:36:00","modified_gmt":"2020-09-24T18:36:00","slug":"alexandre-yersin-prize-for-outstanding-medical-publications-2019-2020-press-releases-septenber-2020","status":"publish","type":"page","link":"https:\/\/helvietmed.org\/vi\/alexandre-yersin-prize-for-outstanding-medical-publications-2019-2020-press-releases-septenber-2020\/","title":{"rendered":"Alexandre Yersin Prize for outstanding medical publications 2019-2020- Press releases september 2020"},"content":{"rendered":"<p><a href=\"https:\/\/helvietmed.org\/wp-content\/uploads\/2020\/09\/Prix-Alexandre-Yersin-2019-2020-Press-release-in-English.docx\">Prix Alexandre Yersin 2019-2020- Press release in English<\/a><\/p>\n<p><strong>Alexandre Prize for Outstanding Medical Publications<\/strong><\/p>\n<p><strong>2nd Edition <\/strong><strong>2019<\/strong><strong>-2020<\/strong><\/p>\n<p><strong>Press Release<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>The Alexandre Yersin Prize for Outstanding Publications was created by the Swiss-Vietnamese Medical Association (HELVIETMED) to recognize Vietnamese scientists who have made important contributions to the medical literature, and through peer-reviewed publications, they help build Vietnam reputation in the international medical research community. Another goal of the Prize is to foster national and international collaborations for medical education and better health care.<\/p>\n<p>The second Prize is based on the best publication in the 24 months prior to the closing date of the award on 31 December 2019. Each publication was evaluated using 5 objective and standardized criteria, including scientific quality, clinical significance, scientific impact, innovation and journal prestige. The Prize is only intended for research that is conducted in Vietnam and by Vietnamese principal investigator. The judging panel, which included 7 professors and doctors from Switzerland, France and Australia, was chaired by Professor Tuan V. Nguyen of the Garvan Institute of Medical Research, University of New South Wales, and University of Technology Sydney Australia. (Professor Nguyen did not evaluate papers that he was involved).<\/p>\n<p>The Prize is named in honour of Dr. Alexandre \u00c9mile-John Yersin (1863 \u2013 1943) who was a great, world-renowned pioneer, and a devoted promotor of medical research and education in Vietnam. With his discovery of the\u00a0<em>plague bacillus,<\/em>\u00a0<em>Yersinia pestis, <\/em>he made fundamental contributions to the etiologic knowledge of plague and helped eliminate the epidemic disease that claimed millions of people over the centuries.<\/p>\n<p>The second edition was greatly welcome by the Vietnamese medical community and the Jury received 23 high quality publications from several teams of researchers from Hanoi, Hue, Danang and Ho Chi Minh City (some publications are produced in collaboration with Swiss institutions). Three best publications were selected. HELVIETMED and the Consulate General of Switzerland in Ho Chi Minh City are pleased to announce three winners of this year&#8217;s Alexandre Yersin Prize for Outstanding Publications:<\/p>\n<ul>\n<li>Dr. Phuong K. T. Nguyen (Danang Hospital for Women and Children)<\/li>\n<li>Dr. Trung T. Ngo (Hospital 108, Hanoi)<\/li>\n<li>Dr. Vinh Q. Dang (My Duc Hospital, Ho Chi Minh City).<\/li>\n<\/ul>\n<p>Each winner will receive a cash award of 30 million VND and a testimonial of recognition.<\/p>\n<p>Due to the exceptional situation caused by COVID-19, Helvietmed and the Consulate General decided do not organize a big award ceremony in a crowded auditorium. The winners are invited individually to the Consulate General of Switzerland in Ho Chi Minh City to attend a simple handover of the certificates by the Consul General of Switzerland Martin Maier<\/p>\n<p><strong><u>Summary of three award winning publications:<\/u><\/strong><\/p>\n<p><strong>Phuong<\/strong><strong> T K Nguyen, et al. <\/strong><strong>Predictors of Unlikely Bacterial Pneumonia and Adverse Pneumonia Outcome in Children Admitted to a Hospital in Central Vietnam. <em>Clinical Infectious Diseases<\/em> 2020 Apr 10;70(8):1733-1741.<\/strong><\/p>\n<p>Pneumonia is the leading cause of antibiotic use and hospitalization in Vietnam. However, some patients were probably hospitalized unnecessarily. The present study sought to develop a prediction model for identifying appropriate patients for hospitalization and rational use of antibiotic medications.<\/p>\n<p>The authors analyzed data from 3,817 children aged between 2 and 59 months who were clinically diagnosed as having pneumonia. However, based on the World Health Organization (WHO) pneumonia criteria, approximately 42% of the patients were classified as unlikely bacterial pneumonia, and only 3.4% as having likely bacterial pneumonia. This result suggests that many patients were probably hospitalized unnecessarily, and that they were put on antibiotic use unnecessarily. The authors employed a Bayesian method to identify factors that could help reduce unnecessary antibiotic use and hospital admission. This work has potential to change the management of pneumonia and better use of antibiotics.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Ngo Tat<\/strong> <strong>Trung<\/strong><strong>, et al.<\/strong> <strong>PCR-based Sepsis@Quick test is superior in comparison with blood culture for identification of sepsiscausative pathogens. <em>Scientific Reports<\/em> 2019; 9:13663.<\/strong><\/p>\n<p>Sepsis is an acute but often life-threatening problem to patients. At present, blood culture (BC) is the gold standard for the identification of pathogens; however, this method is time-consuming and can only detect microbes that readily grow under culture conditions. In this study, Dr. Trung and colleagues sought to develop a new diagnostic tool for early diagnosis of sepsis.<\/p>\n<p>Based on data from 114 blood samples collected from patients who were hospitalized at the 108 Hospital (Hanoi), the investigators have developed a tool called <strong>Sepsis@Quick<\/strong> that removes human DNA from patients\u2019 blood specimens, hence facilitates a detection of rare bacterial genetic materials. Results of this study demonstrated that compared to BC, Sepsis@Quick was better at identifying more pathogens and even polymicrobial infection, faster and less influenced by the empirical administration of broad spectrum antibiotic therapy. Moreover, positive results achieved by Sepsis@Quick were significantly associated with a reduction of sepsis-related mortality risk. This innovative work will improve the accuracy of sepsis diagnosis, and has potential of saving lives.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u0110\u1eb7ng Quang Vinh<\/strong>: <strong>Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm A Randomized Controlled Trial. <em>Obstetrics<\/em><\/strong><strong><em> &amp; Gynecology<\/em><\/strong><strong> 2019; <\/strong><strong>133<\/strong><strong>:459-467. <\/strong><\/p>\n<p>Short cervix is one of the key factors that lead to preterm birth, especially in women with twin pregnancies. The present study was aimed at comparing the effectiveness of cervical pessary to vaginal progesterone for the prevention of preterm birth among women with twin pregnancies and short cervix.<\/p>\n<p>The study was a randomized controlled trial with the setting being My Duc Hospital (Ho Chi Minh City). Three hundred women were randomized into two groups: 150 women in the cervical pessary, and 150 women on 400 mg vaginal progesterone. The key result showed that the rate of preterm birth was not different between those on cervical pessary and those on 400 mg vaginal progesterone. <strong>However, the women on the cervical pessary group had less perinatal complications (respiratory distress syndrome and neonatal sepsis) than those on vaginal progesterone. <\/strong><\/p>\n<p><strong>These results provide good evidence for the preference of pessary over vaginal progesterone in women with twin pregnancies and short cervix. <\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>_______<\/p>\n<p>&nbsp;<\/p>\n<p>For more information, please contact Dr. Quan-Vinh Nguyen (President of HELVIETMED) on Qvnguyen@swissonline.ch, or Professor Tuan V. Nguyen (Chair, Scientific Committee) on tuan.nguyen@unsw.edu.au.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/helvietmed.org\/wp-content\/uploads\/2020\/09\/Prix-Alexandre-Yersin-2019-2020-Press-release-in-French.docx\">Prix Alexandre Yersin 2019-2020- Press release in French<\/a><\/p>\n<p><strong>Prix \u200b\u200bAlexandre Yersin pour publications m\u00e9dicales exceptionnelles Deuxi\u00e8me \u00e9dition 2019-2020\u00a0<\/strong><\/p>\n<p><strong>Communiqu\u00e9 de presse<\/strong><\/p>\n<p>Le Prix Alexandre Yersin a \u00e9t\u00e9 cr\u00e9\u00e9 par l&#8217;Association m\u00e9dicale suisse-vietnamienne (HELVIETMED) pour r\u00e9compenser et honorer les scientifiques et m\u00e9decins vietnamiens qui &#8211; par leurs contributions importantes \u00e0 la litt\u00e9rature m\u00e9dicale mondiale par le biais des publications \u00e9valu\u00e9es par des pairs &#8211; contribuent \u00e0 renforcer la r\u00e9putation du Vietnam au sein de la communaut\u00e9 m\u00e9dicale mondiale. Un autre objectif du Prix est de favoriser les collaborations nationales et internationales pour l&#8217;\u00e9ducation m\u00e9dicale et l&#8217;am\u00e9lioration des soins de sant\u00e9.<\/p>\n<p>Le Prix Alexandre Yersin de la deuxi\u00e8me \u00e9dition 2019\u20132020 est d\u00e9cern\u00e9 aux meilleurs travaux qui ont \u00e9t\u00e9 publi\u00e9s pendant 24 mois pr\u00e9c\u00e9dant la date de cl\u00f4ture du Prix du 31 d\u00e9cembre 2019. Chaque publication a \u00e9t\u00e9 \u00e9valu\u00e9e en utilisant 5 crit\u00e8res objectifs et standardis\u00e9s comprenant la qualit\u00e9 scientifique, la signification clinique, l&#8217;impact scientifique, l&#8217;innovation et le prestige des revues. Le Prix est uniquement destin\u00e9 \u00e0 la recherche men\u00e9e au Vietnam et par un chercheur vietnamien en qualit\u00e9 d&#8217;investigateur principal. Le jury, compos\u00e9 de 7 professeurs et m\u00e9decins de Suisse, de France et d&#8217;Australie, \u00e9tait pr\u00e9sid\u00e9 par le Professeur Tuan V. Nguyen de l&#8217;Institut Garvan de Recherche M\u00e9dicale, Garvan Institute of Medical Research, University of New South Wales, and University of Technology Sydney Australia.<\/p>\n<p>Le Prix est nomm\u00e9 en l&#8217;honneur du Dr Alexandre \u00c9mile-John Yersin (1863 &#8211; 1943) qui fut un grand pionnier de renomm\u00e9e mondiale et un promoteur d\u00e9vou\u00e9 de la recherche m\u00e9dicale et de l&#8217;\u00e9ducation m\u00e9dicale au Vietnam. Avec sa d\u00e9couverte du bacille pesteux (Yersinia pestis), il a apport\u00e9 une contribution fondamentale \u00e0 la connaissance \u00e9tiologique de la peste et a aid\u00e9 \u00e0 \u00e9liminer cette maladie pand\u00e9mique qui a fait des millions de victimes au cours des si\u00e8cles.<\/p>\n<p>La deuxi\u00e8me \u00e9dition a \u00e9t\u00e9 bien accueillie par la communaut\u00e9 m\u00e9dicale vietnamienne et le Jury a re\u00e7u 23 publications de haute qualit\u00e9 de plusieurs \u00e9quipes de chercheurs de Hanoi, Hue, Danang et\u00a0Ho-Chi-Minh-Ville (quelques publications sont r\u00e9alis\u00e9es en collaboration avec les institutions suisses). Trois meilleures publications ont \u00e9t\u00e9 retenues. L&#8217;Association m\u00e9dicale suisse-vietnamienne (HELVIETMED) et le Consulat G\u00e9n\u00e9ral de Suisse \u00e0 Ho Chi Minh-Ville ont le plaisir d&#8217;annoncer les trois laur\u00e9ats de la deuxi\u00e8me \u00e9dition 2019-2020\u00a0:<\/p>\n<ul>\n<li>Dr Phuong K. T. Nguyen (H\u00f4pital pour femmes et enfants de Danang)<\/li>\n<li>Dr Trung T. Ngo (H\u00f4pital 108, Hanoi)<\/li>\n<li>Dr Vinh Q. Dang (H\u00f4pital My Duc, Ho Chi Minh-Ville).<\/li>\n<\/ul>\n<p>Chaque gagnant recevra un prix en esp\u00e8ces de 30 millions de dongs et un certificat.<\/p>\n<p>Face \u00e0 la situation extraordinaire induite par le COVI D-19, HELVIETMED et le Consulat G\u00e9n\u00e9ral de Suisse ont d\u00e9cid\u00e9 de ne pas organiser la c\u00e9r\u00e9monie de d\u00e9cernement des prix pour le grand public comme il y a deux ans. Les laur\u00e9ats sont invit\u00e9s personnellement au Consulat G\u00e9n\u00e9ral de Suisse \u00e0 Ho Chi Minh-Ville pour recevoir le prix remis par le Consul G\u00e9n\u00e9ral de Suisse Martin Maier.<\/p>\n<p><em>En annexe, merci de trouver le r\u00e9sum\u00e9 de trois publications prim\u00e9es.<\/em><\/p>\n<p><strong><u>R\u00e9sum\u00e9 de trois publications prim\u00e9es:<\/u><\/strong><\/p>\n<p><strong>Phuong<\/strong><strong> T K Nguyen, et al. <\/strong><strong>Predictors of Unlikely Bacterial Pneumonia and Adverse Pneumonia Outcome in Children Admitted to a Hospital in Central Vietnam. <\/strong><strong><em>Clinical Infectious Diseases<\/em><\/strong><strong> 2020 Apr 10;70(8):1733-1741.<\/strong><\/p>\n<p><em>La pneumonie est la principale cause d&#8217;utilisation d&#8217;antibiotiques et d&#8217;hospitalisation au Vietnam. Cependant, certains patients ont probablement \u00e9t\u00e9 hospitalis\u00e9s inutilement. <\/em><\/p>\n<p><em>La pr\u00e9sente \u00e9tude a cherch\u00e9 \u00e0 d\u00e9velopper un mod\u00e8le de pr\u00e9diction pour identifier les patients appropri\u00e9s pour l&#8217;hospitalisation et l&#8217;utilisation rationnelle des antibiotiques.<\/em><\/p>\n<p>Les auteurs ont analys\u00e9 les donn\u00e9es de 3 817 enfants \u00e2g\u00e9s de 2 \u00e0 59 mois qui ont re\u00e7u un diagnostic clinique de pneumonie. Cependant, en appliquant des crit\u00e8res de pneumonie bact\u00e9rienne de l&#8217;Organisation mondiale de la sant\u00e9 (OMS), celle-ci serait consid\u00e9r\u00e9e comme improbable chez environ 42%, et bien probable chez seulement 3,4% des patients, et de probabilit\u00e9 ind\u00e9termin\u00e9e chez les patients restants. Ce r\u00e9sultat sugg\u00e8re que chez de nombreux patients l\u2019hospitalisation ainsi que l\u2019antibioth\u00e9rapie ont \u00e9t\u00e9 inutiles.<\/p>\n<p>En utilisant la m\u00e9thode de statistique bay\u00e9sienne, les auteurs ont identifi\u00e9 les facteurs qui permettraient de r\u00e9duire l&#8217;utilisation inutile d&#8217;antibiotiques et le nombre d\u2019hospitalisations non-n\u00e9cessaires.<\/p>\n<p>Ces r\u00e9sultats ont le potentiel de changer la gestion de la pneumonie et une meilleure utilisation des antibiotiques.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Ngo Tat<\/strong> <strong>Trung<\/strong><strong>, et al.<\/strong> <strong>PCR-based Sepsis@Quick test is superior in comparison with blood culture for identification of sepsiscausative pathogens. <\/strong><strong><em>Scientific Reports<\/em><\/strong><strong> 2019; 9:13663.<\/strong><\/p>\n<p>La septic\u00e9mie est un probl\u00e8me aigu et souvent mortel pour les patients. \u00c0 l&#8217;heure actuelle, l&#8217;h\u00e9moculture est l&#8217;\u00e9talon d\u2019or pour l&#8217;identification des agents pathog\u00e8nes; cependant, cette m\u00e9thode prend du temps et ne peut d\u00e9tecter que les microbes qui se d\u00e9veloppent facilement dans des conditions de culture. Dans cette \u00e9tude, le Dr Trung et ses coll\u00e8gues ont cherch\u00e9 \u00e0 d\u00e9velopper un nouvel outil de diagnostic pour le diagnostic pr\u00e9coce de la septic\u00e9mie.<\/p>\n<p>A partir de 114 \u00e9chantillons de sang pr\u00e9lev\u00e9s sur des patients hospitalis\u00e9s \u00e0 l&#8217;h\u00f4pital 108 (Hanoi), les enqu\u00eateurs ont d\u00e9velopp\u00e9 un outil appel\u00e9 Sepsis @ Quick. Cet outil permet de d\u00e9tecter plus facilement le mat\u00e9riel g\u00e9n\u00e9tique bact\u00e9rien pr\u00e9sent en tr\u00e8s faible quantit\u00e9 dans le sang en supprimant l&#8217;ADN humain pr\u00e9sent en quantit\u00e9 importante. Les r\u00e9sultats de cette \u00e9tude ont d\u00e9montr\u00e9 que compar\u00e9 \u00e0 l\u2019h\u00e9moculture, Sepsis @ Quick \u00e9tait meilleur\u00a0:<\/p>\n<ol>\n<li>pour identifier davantage d&#8217;agents pathog\u00e8nes pr\u00e9sents soit seuls et uniques, soit en pluralit\u00e9 comme dans le cadre d\u2019une infection poly-microbienne\u00a0;<\/li>\n<li>pour d\u00e9tecter plus rapidement les pathog\u00e8nes<\/li>\n<li>parce qu\u2019il est moins influenc\u00e9 par l&#8217;administration empirique pr\u00e9alable d&#8217;une antibioth\u00e9rapie \u00e0 large spectre.<\/li>\n<\/ol>\n<p>De plus et de mani\u00e8re plus importante encore, les r\u00e9sultats positifs obtenus par Sepsis @ Quick \u00e9taient significativement associ\u00e9s \u00e0 une r\u00e9duction du risque de mortalit\u00e9 li\u00e9 \u00e0 la septic\u00e9mie.<\/p>\n<p>Ce travail novateur am\u00e9liorera la pr\u00e9cision et la rapidit\u00e9 du diagnostic de la septic\u00e9mie et a le potentiel de sauver des vies.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u0110\u1eb7ng Quang Vinh<\/strong>: <strong>Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm A Randomized Controlled Trial. <\/strong><strong><em>Obstetrics<\/em><\/strong><strong><em> &amp; Gynecology<\/em><\/strong><strong> 2019; <\/strong><strong>133<\/strong><strong>:459-467. <\/strong><\/p>\n<p>Le col de l&#8217;ut\u00e9rus court est l&#8217;un des principaux facteurs qui conduisent \u00e0 une naissance pr\u00e9matur\u00e9e, en particulier chez les femmes ayant des grossesses g\u00e9mellaires. La pr\u00e9sente \u00e9tude visait \u00e0 comparer l&#8217;efficacit\u00e9 du pessaire cervical \u00e0 la progest\u00e9rone vaginale pour la pr\u00e9vention de l&#8217;accouchement pr\u00e9matur\u00e9 chez les femmes ayant des grossesses g\u00e9mellaires et un col court.<\/p>\n<p>L&#8217;\u00e9tude \u00e9tait un essai contr\u00f4l\u00e9 randomis\u00e9 r\u00e9alis\u00e9 \u00e0 l&#8217;h\u00f4pital My Duc (Ho Chi Minh-Ville). Trois cents femmes ont \u00e9t\u00e9 randomis\u00e9es en deux groupes: 150 femmes assign\u00e9es au groupe avec pessaire cervical et 150 femmes assign\u00e9es au groupe recevant 400 mg de progest\u00e9rone en application vaginale.<\/p>\n<p>Le r\u00e9sultat cl\u00e9 a montr\u00e9 que le taux d&#8217;accouchement pr\u00e9matur\u00e9 n&#8217;\u00e9tait pas diff\u00e9rent entre les deux groupes.<\/p>\n<p>Cependant, les femmes du groupe pessaire cervival avaient moins de complications s\u00e9v\u00e8res comme syndrome de d\u00e9tresse respiratoire ou sepsis n\u00e9onatal.<\/p>\n<p>Ces r\u00e9sultats fournissent des arguments en faveur de l\u2019utilisation du pessaire cervical chez les femmes ayant une grossesse g\u00e9mellaire et un col court.<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>Pour plus d&#8217;informations, veuillez contacter le Dr Quan-Vinh Nguyen (Pr\u00e9sident d&#8217;HELVIETMED) sur Qvnguyen@swissonline.ch, ou le Professeur Tuan V. Nguyen (Pr\u00e9sident, Comit\u00e9 scientifique) sur tuan.nguyen@unsw.edu.au.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/helvietmed.org\/wp-content\/uploads\/2020\/09\/Prix-Alexandre-Yersin-2019-2020-Press-release-in-Vietnamese.docx\">Prix Alexandre Yersin 2019-2020- Press release in Vietnamese<\/a><\/p>\n<p><strong>Gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin cho c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u xu\u1ea5t s\u1eafc<\/strong><\/p>\n<p><strong>L\u1ea7n 2 n\u0103m 2019 &#8211; 2020<\/strong><\/p>\n<p><strong>Th\u00f4ng c\u00e1o b\u00e1o ch\u00ed<\/strong><\/p>\n<p>Gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin cho c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u xu\u1ea5t s\u1eafc l\u00e0 m\u1ed9t s\u00e1ng ki\u1ebfn c\u1ee7a H\u1ed9i Y khoa Th\u1ee5y S\u0129 &#8211; Vi\u1ec7t Nam (HELVIETMED) nh\u1eb1m ghi nh\u1eadn \u0111\u00f3ng g\u00f3p c\u1ee7a c\u00e1c nh\u00e0 khoa h\u1ecdc Vi\u1ec7t Nam cho y v\u0103n qu\u1ed1c t\u1ebf. Qua c\u00f4ng b\u1ed1 qu\u1ed1c t\u1ebf, h\u1ecd gi\u00fap x\u00e2y d\u1ef1ng uy t\u00edn c\u1ee7a Vi\u1ec7t Nam trong c\u1ed9ng \u0111\u1ed3ng khoa h\u1ecdc th\u1ebf gi\u1edbi. M\u1ed9t m\u1ee5c ti\u00eau kh\u00e1c c\u1ee7a Gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin l\u00e0 c\u1ed5 v\u0169 h\u1ee3p t\u00e1c nghi\u00ean c\u1ee9u c\u1ea5p qu\u1ed1c gia v\u00e0 qu\u1ed1c t\u1ebf nh\u1eb1m c\u1ea3i thi\u1ec7n ph\u1ea9m ch\u1ea5t ch\u0103m s\u00f3c b\u1ec7nh nh\u00e2n.<\/p>\n<p>Gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin l\u1ea7n 2 n\u0103m 2019-2020 \u0111\u01b0\u1ee3c trao cho nh\u1eefng c\u00f4ng tr\u00ecnh \u0111\u00e3 c\u00f4ng b\u1ed1 tr\u00ean c\u00e1c t\u1eadp san y h\u1ecdc trong v\u00f2ng 24 th\u00e1ng t\u00ednh \u0111\u1ebfn ng\u00e0y trao gi\u1ea3i, ng\u00e0y 31 th\u00e1ng 12 n\u0103m 2019. M\u1ed7i c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 qua 5 ti\u00eau chu\u1ea9n: ph\u1ea9m ch\u1ea5t khoa h\u1ecdc, t\u1ea7m \u1ea3nh h\u01b0\u1edfng trong l\u00e2m s\u00e0ng, \u1ea3nh h\u01b0\u1edfng trong khoa h\u1ecdc, t\u00ednh c\u00e1ch t\u00e2n, v\u00e0 uy danh c\u1ee7a t\u1eadp san khoa h\u1ecdc. Gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin ch\u1ec9 d\u00e0nh cho c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n \u1edf Vi\u1ec7t Nam b\u1edfi nh\u00e0 khoa h\u1ecdc Vi\u1ec7t Nam ch\u1ee7 tr\u00ec. H\u1ed9i \u0111\u1ed3ng th\u1ea9m \u0111\u1ecbnh bao g\u1ed3m 7 gi\u00e1o s\u01b0 v\u00e0 b\u00e1c s\u0129 t\u1eeb Th\u1ee5y S\u1ef9, Ph\u00e1p, v\u00e0 \u00dac, d\u01b0\u1edbi s\u1ef1 ch\u1ee7 tr\u00ec c\u1ee7a Gi\u00e1o s\u01b0 Nguy\u1ec5n V\u0103n Tu\u1ea5n thu\u1ed9c Vi\u1ec7n nghi\u00ean c\u1ee9u Y khoa Garvan, \u0110\u1ea1i h\u1ecdc New South Wales, v\u00e0 \u0110\u1ea1i h\u1ecdc C\u00f4ng ngh\u1ec7 Sydney.<\/p>\n<p>Gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin \u0111\u01b0\u1ee3c l\u1eadp ra \u0111\u1ec3 vinh danh B\u00e1c s\u0129 Alexandre \u00c9mile-John Yersin (1863 \u2013 1943), m\u1ed9t nh\u00e0 nghi\u00ean c\u1ee9u y h\u1ecdc ti\u1ec1n phong c\u1ee7a Vi\u1ec7t Nam. \u00d4ng c\u0169ng l\u00e0 ng\u01b0\u1eddi \u0111\u00e3 kh\u00e1m ph\u00e1 Vi Tr\u00f9ng D\u1ecbch H\u1ea1ch<em> Yersinia pestis.\u00a0<\/em>Nh\u1eefng c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u c\u1ee7a \u00f4ng th\u1ec3 hi\u1ec7n nh\u1eefng \u0111\u00f3ng g\u00f3p mang t\u00ednh c\u01a1 b\u1ea3n trong y h\u1ecdc, \u0111\u1eb7c bi\u1ec7t li\u00ean quan \u0111\u1ebfn b\u1ec7nh truy\u1ec1n nhi\u1ec5m v\u00e0 \u0111\u00e3 gi\u00fap x\u00f3a b\u1ecf m\u1ed9t s\u1ed1 d\u1ecbch b\u1ec7nh v\u00e0 c\u1ee9u h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean th\u1ebf gi\u1edbi.<\/p>\n<p>Gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin l\u1ea7n 2 n\u0103m 2019-2020 \u0111\u00e3 nh\u1eadn \u0111\u01b0\u1ee3c s\u1ef1 quan t\u00e2m \u0111\u1eb7c bi\u1ec7t c\u1ee7a c\u1ed9ng \u0111\u1ed3ng y khoa t\u1ea1i Vi\u1ec7t Nam. Ban t\u1ed5 ch\u1ee9c \u0111\u00e3 nh\u1eadn \u0111\u01b0\u1ee3c t\u1ed5ng c\u1ed9ng 23 b\u00e0i d\u1ef1 thi c\u1ee7a nhi\u1ec1u nh\u00f3m nghi\u00ean c\u1ee9u \u0111\u1ebfn t\u1eeb H\u00e0 N\u1ed9i, Hu\u1ebf, \u0110\u00e0 N\u1eb5ng v\u00e0 Th\u00e0nh ph\u1ed1 H\u1ed3 Ch\u00ed Minh (M\u1ed9t v\u00e0i c\u00f4ng tr\u00ecnh d\u1ef1 thi l\u00e0 s\u1ea3n ph\u1ea9m c\u1ee7a s\u1ef1 h\u1ee3p t\u00e1c nghi\u00ean c\u1ee9u v\u1edbi c\u00e1c Vi\u1ec7n c\u1ee7a Th\u1ee5y S\u1ef9). Ba b\u00e0i d\u1ef1 thi xu\u1ea5t s\u1eafc nh\u1ea5t \u0111\u00e3 \u0111\u01b0\u1ee3c ban gi\u00e1m kh\u1ea3o l\u1ef1a ch\u1ecdn \u0111\u1ec3 trao gi\u1ea3i. Hi\u1ec7p h\u1ed9i HELVIETMED v\u00e0 T\u1ed5ng L\u00e3nh s\u1ef1 qu\u00e1n Th\u1ee5y S\u1ef9 t\u1ea1i Th\u00e0nh ph\u1ed1 H\u1ed3 Ch\u00ed Minh h\u00e2n h\u1ea1nh th\u00f4ng b\u00e1o 3 nh\u00e0 khoa h\u1ecdc \u0111\u01b0\u1ee3c trao gi\u1ea3i th\u01b0\u1edfng Alexandre Yersin cho c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u xu\u1ea5t s\u1eafc n\u0103m 2020 l\u00e0<strong>: <\/strong><\/p>\n<ul>\n<li>Bs Nguy\u1ec5n Th\u1ecb Kim Ph\u01b0\u01a1ng v\u00e0 c\u1ed9ng s\u1ef1, thu\u1ed9c B\u1ec7nh vi\u1ec7n Ph\u1ee5 s\u1ea3n &#8211; Nhi, \u0110\u00e0 N\u1eb5ng<\/li>\n<li>Ts Ng\u00f4 T\u1ea5t Trung v\u00e0 c\u1ed9ng s\u1ef1 thu\u1ed9c B\u1ec7nh vi\u1ec7n 108, H\u00e0 N\u1ed9i<\/li>\n<li>Bs \u0110\u1eb7ng Quang Vinh v\u00e0 c\u1ed9ng s\u1ef1 thu\u1ed9c B\u1ec7nh vi\u1ec7n M\u1ef9 \u0110\u1ee9c, Th\u00e0nh ph\u1ed1 H\u1ed3 Ch\u00ed Minh.<\/li>\n<\/ul>\n<p>M\u1ed7i nh\u00f3m khoa h\u1ecdc s\u1ebd nh\u1eadn \u0111\u01b0\u1ee3c gi\u1ea3i th\u01b0\u1edfng tr\u1ecb gi\u00e1 30 tri\u1ec7u \u0111\u1ed3ng b\u1eb1ng ti\u1ec1n m\u1eb7t v\u00e0 m\u1ed9t ch\u1ee9ng nh\u1eadn v\u1ec1 th\u00e0nh t\u1ef1u nghi\u00ean c\u1ee9u.<\/p>\n<p>N\u0103m nay do di\u1ec5n bi\u1ebfn ph\u1ee9c t\u1ea1p c\u1ee7a d\u1ecbch Covid-19, HELVIETMED v\u00e0 T\u1ed5ng L\u00e3nh s\u1ef1 qu\u00e1n Th\u1ee5y S\u1ef9 quy\u1ebft \u0111\u1ecbnh kh\u00f4ng t\u1ed5 ch\u1ee9c l\u1ec5 trao gi\u1ea3i t\u1eadp trung \u0111\u00f4ng ng\u01b0\u1eddi nh\u01b0 \u0111\u00e3 l\u00e0m c\u00e1ch \u0111\u00e2y 2 n\u0103m. Ng\u01b0\u1eddi th\u1eafng gi\u1ea3i s\u1ebd \u0111\u01b0\u1ee3c m\u1eddi \u0111\u1ebfn T\u1ed5ng L\u00e3nh s\u1ef1 qu\u00e1n Th\u1ee5y S\u1ef9 t\u1ea1i Th\u00e0nh ph\u1ed1 H\u1ed3 Ch\u00ed Minh \u0111\u1ec3 nh\u1eadn gi\u1ea3i th\u01b0\u1edfng do \u0111\u00edch th\u00e2n T\u1ed5ng L\u00e3nh s\u1ef1 Martin Maier trao t\u1eb7ng.<\/p>\n<p>&nbsp;<\/p>\n<p><em>Xin vui l\u00f2ng xem t\u00e0i li\u1ec7u \u0111\u00ednh k\u00e8m \u0111\u1ec3 bi\u1ebft th\u00eam chi ti\u1ebft v\u1ec1 c\u00e1c c\u00f4ng tr\u00ecnh \u0111o\u1ea1t gi\u1ea3i.<\/em><\/p>\n<p><strong><u>T\u00f3m l\u01b0\u1ee3c ba c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u \u0111\u01b0\u1ee3c trao gi\u1ea3i th\u01b0\u1edfng: <\/u><\/strong><\/p>\n<p><strong>Nguy\u1ec5n Th\u1ecb<\/strong> <strong>Kim Ph\u01b0\u01a1ng<\/strong>: <strong>Predictors of Unlikely Bacterial Pneumonia and Adverse Pneumonia Outcome in Children Admitted to a Hospital in Central Vietnam. <em>Clinical Infectious Diseases<\/em> 2020 Apr 10;70(8):1733-1741.<\/strong><\/p>\n<p>Vi\u00eam ph\u1ed5i l\u00e0 nguy\u00ean nh\u00e2n h\u00e0ng \u0111\u1ea7u c\u1ee7a vi\u1ec7c s\u1eed d\u1ee5ng kh\u00e1ng sinh v\u00e0 nh\u1eadp vi\u1ec7n t\u1ea1i Vi\u1ec7t Nam. Nh\u01b0ng m\u1ed9t s\u1ed1 tr\u01b0\u1eddng h\u1ee3p nh\u1eadp vi\u1ec7n c\u00f3 th\u1ec3 kh\u00f4ng c\u1ea7n thi\u1ebft v\u00e0 c\u00f3 th\u1ec3 g\u00f3p ph\u1ea7n v\u00e0o t\u00ecnh tr\u1ea1ng qu\u00e1 t\u1ea3i c\u1ee7a b\u1ec7nh vi\u1ec7n. Trong c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u n\u00e0y, c\u00e1c t\u00e1c gi\u1ea3 nh\u1eafm \u0111\u1ebfn m\u1ee5c ti\u00eau x\u00e2y d\u1ef1ng m\u00f4 h\u00ecnh ti\u00ean l\u01b0\u1ee3ng t\u1ed1t h\u01a1n v\u1ec1 c\u00e1c ca b\u1ec7nh kh\u00f4ng ch\u1eafc l\u00e0 vi\u00eam ph\u1ed5i \u0111\u1ec3 c\u00f3 h\u01b0\u1edbng d\u1eabn nh\u1eadp vi\u1ec7n v\u00e0 c\u1ea3i thi\u1ec7n t\u00ecnh h\u00ecnh s\u1eed d\u1ee5ng kh\u00e1ng sinh m\u1ed9t c\u00e1ch h\u1ee3p l\u00fd. C\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u ph\u00e2n t\u00edch d\u1eef li\u1ec7u c\u1ee7a 3.817 tr\u1ebb em tu\u1ed5i t\u1eeb 2 \u2013 59 th\u00e1ng \u0111\u01b0\u1ee3c c\u00e1c b\u00e1c s\u0129 l\u00e2m s\u00e0ng ch\u1ea9n \u0111o\u00e1n &#8216;vi\u00eam ph\u1ed5i&#8217; v\u00e0 nh\u1eadp vi\u1ec7n \u1edf \u0110\u00e0 N\u1eb5ng. Th\u1eddi gian n\u1eb1m vi\u1ec7n trung b\u00ecnh t\u1ea7m 7 ng\u00e0y v\u00e0 chi ph\u00ed trung b\u00ecnh 253 USD.<\/p>\n<p>K\u1ebft qu\u1ea3 cho th\u1ea5y n\u1ebfu d\u00f9ng ti\u00eau chu\u1ea9n c\u1ee7a T\u1ed5 ch\u1ee9c Y t\u1ebf Th\u1ebf gi\u1edbi (WHO) th\u00ec g\u1ea7n 42% b\u1ec7nh nhi kh\u00f4ng \u0111\u01b0\u1ee3c xem l\u00e0 &#8216;vi\u00eam ph\u1ed5i&#8217;, v\u00e0 ch\u1ec9 c\u00f3 3,4% \u0111\u00e1p \u1ee9ng ti\u00eau chu\u1ea9n &#8216;vi\u00eam ph\u1ed5i n\u1eb7ng&#8217;. K\u1ebft qu\u1ea3 n\u00e0y cho th\u1ea5y \u0111a s\u1ed1 ca nh\u1eadp vi\u1ec7n c\u00f3 l\u1ebd l\u00e0 kh\u00f4ng c\u1ea7n thi\u1ebft, v\u00e0 do \u0111\u00f3 vi\u1ec7c s\u1eed d\u1ee5ng kh\u00e1ng sinh cho nhi\u1ec1u ca nh\u1eadp vi\u1ec7n c\u0169ng kh\u00f4ng c\u1ea7n thi\u1ebft. Qua \u1ee9ng d\u1ee5ng m\u1ed9t m\u00f4 h\u00ecnh Bayes, c\u00e1c t\u00e1c gi\u1ea3 \u0111\u00e3 x\u00e1c \u0111\u1ecbnh \u0111\u01b0\u1ee3c nh\u1eefng y\u1ebfu t\u1ed1 c\u00f3 th\u1ec3 gi\u00fap cho vi\u1ec7c x\u00e2y d\u1ef1ng m\u1ed9t m\u00f4 h\u00ecnh ti\u00ean l\u01b0\u1ee3ng v\u00e0 gi\u00fap s\u00e0ng l\u1ecdc vi\u00eam ph\u1ed5i t\u1ed1t h\u01a1n.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Ng\u00f4 T\u1ea5t Trung<\/strong>: <strong>PCR-based Sepsis@Quick test is superior in comparison with blood culture for identification of sepsiscausative pathogens. <em>Scientific Reports<\/em> 2019; 9:13663.<\/strong><\/p>\n<p>Nhi\u1ec5m tr\u00f9ng huy\u1ebft (sepsis) l\u00e0 m\u1ed9t h\u1ed9i ch\u1ee9ng c\u1ea5p t\u00ednh, th\u01b0\u1eddng g\u00e2y t\u1eed vong, c\u1ea7n ch\u1ea9n \u0111o\u00e1n s\u1edbm v\u00e0 \u0111i\u1ec1u tr\u1ecb \u0111\u00fang c\u00e1ch. Hi\u1ec7n nay, c\u1ea5y m\u00e1u (blood culture) \u0111\u01b0\u1ee3c xem l\u00e0 ti\u00eau chu\u1ea9n v\u00e0ng \u0111\u1ec3 ch\u1ea9n \u0111o\u00e1n m\u1ea7m b\u1ec7nh trong nhi\u1ec5m khu\u1ea9n huy\u1ebft. Tuy nhi\u00ean, vi\u1ec7c l\u1ea5y m\u1ed9t l\u01b0\u1ee3ng m\u00e1u l\u1edbn, \u0111\u1eb7c bi\u1ec7t \u1edf c\u00e1c b\u1ec7nh nhi s\u01a1 sinh, l\u00e0 \u0111i\u1ec1u kh\u00f3 kh\u0103n v\u00e0 quy tr\u00ecnh th\u1ef1c hi\u1ec7n x\u00e9t nghi\u1ec7m n\u00e0y th\u01b0\u1eddng k\u00e9o d\u00e0i t\u1eeb 48-72 gi\u1edd m\u1edbi c\u00f3 k\u1ebft qu\u1ea3 s\u01a1 b\u1ed9. T\u00ecnh tr\u1ea1ng n\u00e0y c\u00f3 th\u1ec3 l\u00e0m tr\u00ec ho\u00e3n qu\u00e1 tr\u00ecnh \u0111i\u1ec1u tr\u1ecb. C\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u nh\u1eb1m m\u1ee5c ti\u00eau ph\u00e1t tri\u1ec3n m\u1ed9t ph\u01b0\u01a1ng ph\u00e1p ch\u1ea9n \u0111o\u00e1n nhi\u1ec5m tr\u00f9ng huy\u1ebft nhanh h\u01a1n v\u00e0 t\u1ed1t h\u01a1n.<\/p>\n<p>D\u1ef1a tr\u00ean 114 m\u1eabu m\u00e1u c\u1ee7a b\u1ec7nh nh\u00e2n t\u1ea1i B\u1ec7nh vi\u1ec7n 108, nh\u00f3m nghi\u00ean c\u1ee9u \u0111\u00e3 s\u1eed d\u1ee5ng m\u1ed9t k\u1ef9 thu\u1eadt kh\u00e1c d\u1ef1a tr\u00ean ph\u1ea3n \u1ee9ng chu\u1ed7i polymerase (PCR) \u0111\u1ec3 ph\u00e1t hi\u1ec7n DNA c\u1ee7a vi khu\u1ea9n trong m\u1eabu m\u00e1u c\u1ee7a b\u1ec7nh nh\u00e2n, nh\u1eb1m gi\u00fap x\u00e9t nghi\u1ec7m nhi\u1ec5m khu\u1ea9n huy\u1ebft v\u1edbi \u0111\u1ed9 nh\u1ea1y cao v\u00e0 th\u1eddi gian th\u1ef1c hi\u1ec7n nhanh h\u01a1n. Nh\u00f3m nghi\u00ean c\u1ee9u \u0111\u00e3 t\u1ea1o ra b\u1ed9 ch\u1ea9n \u0111o\u00e1n x\u00e9t nghi\u1ec7m nhanh <strong>Sepsis@Quick <\/strong>cho k\u1ebft qu\u1ea3 trong 4 gi\u1edd. K\u1ebft qu\u1ea3 so s\u00e1nh th\u1ef1c nghi\u1ec7m cho th\u1ea5y Sepsis@Quick cho ra k\u1ebft qu\u1ea3 v\u01b0\u1ee3t tr\u1ed9i h\u01a1n so v\u1edbi nu\u00f4i c\u1ea5y m\u00e1u, c\u00f3 th\u1ec3 x\u00e1c \u0111\u1ecbnh nhi\u1ec1u m\u1ea7m b\u1ec7nh, v\u00e0 th\u1eadm ch\u00ed nhi\u1ec5m tr\u00f9ng \u0111a b\u00e0o. Ph\u01b0\u01a1ng ph\u00e1p c\u00f2n c\u00f3 t\u1ed1c \u0111\u1ed9 nhanh h\u01a1n v\u00e0 \u00edt b\u1ecb \u1ea3nh h\u01b0\u1edfng b\u1edfi vi\u1ec7c \u0111i\u1ec1u tr\u1ecb b\u1eb1ng kh\u00e1ng sinh ph\u1ed5 r\u1ed9ng. C\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u n\u00e0y \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 l\u00e0 c\u00e1ch t\u00e2n v\u00e0 c\u00f3 ti\u1ec1m n\u0103ng ch\u1ea9n \u0111o\u00e1n nhi\u1ec5m tr\u00f9ng m\u00e1u nhanh h\u01a1n v\u00e0 qua \u0111\u00f3 gi\u00fap c\u1ee9u s\u1ed1ng b\u1ec7nh nh\u00e2n.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u0110\u1eb7ng Quang Vinh<\/strong>: <strong>Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm A Randomized Controlled Trial. <em>Obstetrics<\/em><\/strong><strong><em> &amp; Gynecology<\/em><\/strong><strong> 2019; <\/strong><strong>133<\/strong><strong>:459-467. <\/strong><\/p>\n<p>C\u1ed5 t\u1eed cung ng\u1eafn l\u00e0 m\u1ed9t trong nh\u1eefng nguy\u00ean nh\u00e2n d\u1eabn \u0111\u1ebfn sinh non, s\u1ea3y thai, \u0111\u1eb7c bi\u1ec7t l\u00e0 \u1edf ph\u1ee5 n\u1eef mang thai \u0111\u00f4i. Nghi\u00ean c\u1ee9u n\u00e0y c\u00f3 m\u1ee5c ti\u00eau so s\u00e1nh hi\u1ec7u qu\u1ea3 c\u1ee7a 2 ph\u01b0\u01a1ng ph\u00e1p d\u1ef1 ph\u00f2ng sinh non \u1edf ph\u1ee5 n\u1eef mang thai \u0111\u00f4i v\u00e0 c\u00f3 c\u1ed5 t\u1eed cung d\u01b0\u1edbi 38 mm.<\/p>\n<p>C\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u l\u00e0 m\u1ed9t th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 \u0111\u1ed1i ch\u1ee9ng, v\u1edbi ph\u1ee5 n\u1eef \u0111\u01b0\u1ee3c can thi\u1ec7p b\u1eb1ng 2 ph\u01b0\u01a1ng ph\u00e1p: (a) \u0111\u1eb7t v\u00f2ng pessary n\u00e2ng c\u1ed5 t\u1eed cung, v\u00e0 (b) d\u00f9ng thu\u1ed1c ch\u1ee9a progesterone (400mg\/ng\u00e0y) \u0111\u1eb7t t\u1ea1i \u00e2m \u0111\u1ea1o. K\u1ebft qu\u1ea3 nghi\u00ean c\u1ee9u tr\u00ean 300 ph\u1ee5 n\u1eef \u1edf B\u1ec7nh vi\u1ec7n \u0110a khoa M\u1ef9 \u0110\u1ee9c (TP.HCM) cho th\u1ea5y th\u1ea5y r\u1eb1ng c\u1ea3 2 ph\u01b0\u01a1ng ph\u00e1p \u0111\u1ec1u t\u00e1c d\u1ee5ng t\u01b0\u01a1ng t\u1ef1 nhau v\u1edbi t\u1ef7 l\u1ec7 sinh non d\u01b0\u1edbi 34 tu\u1ea7n tu\u1ed5i thai \u1edf nh\u1eefng ph\u1ee5 n\u1eef mang thai \u0111\u00f4i v\u00e0 chi\u1ec1u d\u00e0i c\u1ed5 t\u1eed cung d\u01b0\u1edbi 38 mm. Tuy nhi\u00ean, \u1edf nh\u1eefng ph\u1ee5 n\u1eef c\u00f3 chi\u1ec1u d\u00e0i c\u1ed5 t\u1eed cung ng\u1eafn h\u01a1n (t\u1eeb 28 mm tr\u1edf xu\u1ed1ng) th\u00ec \u0111\u1eb7t v\u00f2ng pessary l\u00e0m gi\u1ea3m \u0111\u00e1ng k\u1ec3 t\u1ef7 l\u1ec7 sinh non d\u01b0\u1edbi 34 tu\u1ea7n tu\u1ed5i h\u01a1n so v\u1edbi d\u00f9ng thu\u1ed1c ch\u1ee9a progesterone.<\/p>\n<p>K\u1ebft qu\u1ea3 nghi\u00ean c\u1ee9u n\u00e0y c\u00f3 \u00fd ngh\u0129a l\u00e2m s\u00e0ng quan tr\u1ecdng, v\u00e0 l\u00e0m c\u01a1 s\u1edf cho nh\u1eefng ph\u00e1c \u0111\u1ed3 gi\u1ea3m t\u00ecnh tr\u1ea1ng sinh non \u1edf ph\u1ee5 n\u1eef mang thai \u0111\u00f4i v\u00e0 c\u00f3 c\u1ed5 t\u1eed cung d\u01b0\u1edbi 38 mm.<\/p>\n<p>________<\/p>\n<p>&nbsp;<\/p>\n<p>\u0110\u1ec3 bi\u1ebft th\u00eam chi ti\u1ebft v\u1ec1 gi\u1ea3i th\u01b0\u1edfng v\u00e0 c\u00e1c c\u00f4ng tr\u00ecnh nghi\u00ean c\u1ee9u c\u00f3 th\u1ec3 li\u00ean l\u1ea1c Bs Nguy\u1ec5n Quan Vinh (Ch\u1ee7 t\u1ecbch H\u1ed9i HELVIETMED) t\u1ea1i \u0111\u1ecba ch\u1ec9 Qvnguyen@swissonline.ch, ho\u1eb7c Gi\u00e1o s\u01b0 Nguy\u1ec5n V\u0103n Tu\u1ea5n (Ch\u1ee7 t\u1ecbch H\u1ed9i \u0111\u1ed3ng Khoa h\u1ecdc) t\u1ea1i \u0111\u1ecba ch\u1ec9 tuan.nguyen@unsw.edu.au.<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Prix Alexandre Yersin 2019-2020- Press release in English Alexandre Prize for Outstanding Medical Publications 2nd Edition 2019-2020 Press Release &nbsp; The Alexandre Yersin Prize for Outstanding Publications was created by the Swiss-Vietnamese Medical Association (HELVIETMED) to recognize Vietnamese scientists who have made important contributions to the medical literature, and through peer-reviewed publications, they help build Vietnam reputation in the international medical research community. Another goal of the Prize is to foster national and international collaborations for medical education and better health care. The second Prize is based on the best publication in the 24 months prior to the closing date of the award on 31 December 2019. Each publication was evaluated using 5 objective and standardized criteria, including scientific quality, clinical significance, scientific impact, innovation and journal prestige. The Prize is only intended for research that is conducted in Vietnam and by Vietnamese principal investigator. The judging panel, which included 7 professors and doctors from Switzerland, France and Australia, was chaired by Professor Tuan V. Nguyen of the Garvan Institute of Medical Research, University of &hellip;<\/p>","protected":false},"author":158048969,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_seo_schema_type":"","_wpcom_ai_launchpad_about_page":false,"_wpcom_ai_launchpad_gallery_page":false,"_wpcom_ai_launchpad_contact_page":false,"_wpcom_ai_launchpad_events_page":false,"_wpcom_ai_launchpad_video_page":false,"_wpcom_ai_launchpad_portfolio_piece":false,"footnotes":""},"class_list":["post-2299","page","type-page","status-publish","hentry"],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/Pb0jKy-B5","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/pages\/2299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/users\/158048969"}],"replies":[{"embeddable":true,"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/comments?post=2299"}],"version-history":[{"count":7,"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/pages\/2299\/revisions"}],"predecessor-version":[{"id":2306,"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/pages\/2299\/revisions\/2306"}],"wp:attachment":[{"href":"https:\/\/helvietmed.org\/vi\/wp-json\/wp\/v2\/media?parent=2299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}